These findings identify BAP31 as an important regulator of hepatic lipid and glucose metabolism and suggest that targeting BAP31-associated pathways may offer new therapeutic opportunities for the prevention and treatment of alcoholic liver disease. This evidence concerns the gene BCAP31 and alcoholic liver diseases.